Global Antibody Contract Manufacturing Market Report 2023 with Profiles of Leading Players AbbVie, Samsung Biologics, Aenova, Cambrex, Eurofins Scientific, AGC Biologics and More
30 nov. 2023 04h03 HE
|
Research and Markets
Dublin, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Antibody Contract Manufacturing Market 2023" report has been added to ResearchAndMarkets.com's offering.The global antibody contract...
United States Oral Solid Dosage Contract Manufacturing Market Analysis Report 2023-2030: Patient-Centric Medication Adherence Spurs Innovation in Oral Dosage Forms
27 nov. 2023 04h53 HE
|
Research and Markets
Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The "U.S. Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Tablets, Capsules), By Mechanism...
Artificial Intelligence Revolutionizes Merchant API Manufacturing as Market Expands at 6.97% CAGR
10 nov. 2023 08h28 HE
|
Research and Markets
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Merchant API Market (by Molecular Type, Segment, Type, Type of Synthesis, End-User, & Region): Insights and Forecast with Potential Impact...
Societal CDMO Reports Third Quarter 2023 Financial Results
08 nov. 2023 16h05 HE
|
Societal CDMO, Inc.
Recorded Q3 Revenue of $23.6 Million Signed Multiple New Business Agreements with New and Existing Customers Closed Public Offering Raising Gross Proceeds of Approximately $8.3 Million Initiated...
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
08 nov. 2023 08h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
North America Leads the Charge in the Booming Biologics CDMO Market with Projected Growth from $6.6 Billion in 2023 to $12.4 Billion by 2028
08 nov. 2023 05h33 HE
|
Research and Markets
Dublin, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The "Biologics Contract Development and Manufacturing Organizations (CDMOs): Global Markets" report has been added to ResearchAndMarkets.com's offering. ...
Scinai Immunotherapeutics Announces Award of Non-Dilutive Grant from Israel Innovation Authority Supporting its New CDMO Business Unit
06 nov. 2023 07h30 HE
|
Scinai Immunotherapeutics Ltd.
JERUSALEM, Nov. 06, 2023 (GLOBE NEWSWIRE) -- via IBN -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) today announced that the Israel Innovation Authority (IIA) has approved a non-dilutive grant...
Societal CDMO to Report Financial Results for Third Quarter 2023 on November 8, 2023
01 nov. 2023 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO)...
Societal CDMO Reports Inducement Grants for New Staff
05 oct. 2023 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
Cell-Easy is pleased to welcome Mrs. Gisele Deblandre, formerly CSO at MaSTherCell, as Chief Scientific Officer
28 sept. 2023 08h15 HE
|
CELL-EASY
Cell-Easy, a contract development and manufacturing organization (CDMO) in cell therapy, proudly announces the appointment of Mrs. Gisele Deblandre.